You are here: Industry Insights > Shanghai Pharma

News List

Shanghai Pharma seeking deals to drive overseas expansion fiercebiotech
January 26, 2018
China’s Shanghai Pharma is planning to open an R&D unit in San Diego as part of an international expansion drive that could also include acquisitions in the U.S. and Europe, according to media reports.
Shanghai Pharma buys drug distribution unit of US-based Cardinal Health biospectrumasia
November 22, 2017
Shanghai Pharma and Cardinal Health have reached a strategic cooperation agreement to explore business development in the U.S., as well as collaborate in developing the global market for medical equipment and service innovation.
Cardinal Health sells off China business to Shanghai Pharma biospectrumasia
November 17, 2017
The $557 million is calculated after deduction of debt and other adjustments from the base payment that values the unit at $1.2 billion.
Amgen’s China biosim deal, Sovaldi’s Chinese nod, Shanghai Pharma’s Alvogen talks fiercepharma
September 30, 2017
Gilead's Chinese nod for Sovaldi, a potential sale of Alvogen's U.S. business to Shanghai Pharma, and more.
Shanghai Pharma partner with DHL to build global pharma network biospectrumasia
August 15, 2017
The deal will give Shanghai Pharma priority access to DHL’s network, including its temperature-controlled life sciences services to Europe